Physiomics (LON:PYC) Trading 7.8% Higher – Should You Buy?

Physiomics Plc (LON:PYC)’s stock price shot up 7.8% during trading on Friday . The stock traded as high as GBX 0.55 and last traded at GBX 0.54. 2,392,465 shares traded hands during trading, a decline of 72% from the average session volume of 8,425,996 shares. The stock had previously closed at GBX 0.50.

Physiomics Stock Up 20.0%

The business has a 50-day moving average price of GBX 0.37 and a 200-day moving average price of GBX 0.40. The firm has a market capitalization of £1.82 million, a P/E ratio of -3.53 and a beta of 1.69.

Physiomics (LON:PYC) last issued its earnings results on Monday, February 16th. The company reported GBX (0.10) earnings per share for the quarter. Physiomics had a negative net margin of 106.80% and a negative return on equity of 127.68%. As a group, sell-side analysts forecast that Physiomics Plc will post -0.13 EPS for the current year.

Physiomics Company Profile

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.